Overview

Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure

Status:
Unknown status
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This is a two-center, randomised, single-blind (physician), prospective, controlled study to assess the acute (8 weeks) and chronic (16 weeks) effects of intravenous (IV) iron sucrose supplementation in anaemic and non-anaemic iron deficient patients with chronic heart failure (CHF). The hypotheses are: - Treatment of anaemic and non-anaemic iron-deficient CHF patients with IV iron sucrose improves exercise capacity as measured by peak VO2. - IV iron sucrose is safe and well tolerated in subjects with moderate to severe CHF.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Heart and Lung Institute
Collaborators:
4th Military Hospital
4th Military Hospital, Poland
Wexham Park Hospital
Treatments:
Ferric Oxide, Saccharated
Iron